Save information for later
Sign Up

Learn About Plasmacytoma

Who are the top Plasmacytoma Local Doctors?
Elite in Plasmacytoma
Hematology Oncology | Oncology
Elite in Plasmacytoma
Hematology Oncology | Oncology

MD Anderson

2130 W Holcombe Blvd, Univ Of Tx M D Ande Life, 
Houston, TX 
Languages Spoken:
English
Offers Telehealth

Robert Orlowski is a Hematologist Oncology specialist and an Oncologist in Houston, Texas. Dr. Orlowski is rated as an Elite provider by MediFind in the treatment of Plasmacytoma. His top areas of expertise are Multiple Myeloma, Plasmacytoma, Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.

Youlia M. Kirova
Elite in Plasmacytoma
Elite in Plasmacytoma
Paris, FR 

Youlia Kirova practices in Paris, France. Kirova is rated as an Elite expert by MediFind in the treatment of Plasmacytoma. Their top areas of expertise are Breast Cancer, Plasmacytoma, Mediastinal Tumor, Hodgkin Lymphoma, and Mastectomy.

 
 
 
 
Learn about our expert tiers
Learn More
Philippe A. Moreau
Elite in Plasmacytoma
Elite in Plasmacytoma
Head And Neck, 
Nantes, FR 

Philippe Moreau practices in Nantes, France. Mr. Moreau is rated as an Elite expert by MediFind in the treatment of Plasmacytoma. His top areas of expertise are Multiple Myeloma, Plasmacytoma, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Bone Marrow Aspiration.

What are the latest Plasmacytoma Clinical Trials?
A Phase I Clinical Study to Evaluate the Safety and Pharmacokinetics of TQB2934 Subcutaneous Preparation for Injection in Subjects With Malignant Plasma Cell Tumors

Summary: TQB2934 is an anti-Cluster of Differentiation 3 (CD3) (Early T Cell Marker)×B cell maturation antigen (BCMA) double-specific antibody,and the isoform is IgG1(Native Immunoglobulin G1), which at one end binds to the CD3 receptor on the surface of T cells ,and the other end binds to BCMA(B cell maturation antigen) to recruit T cells around BCMA-positive cells, which can activate T cells .Active T ce...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Collection of Specimens and Clinical Data to Create A Bio-repository for the Multiple Myeloma Program: The Indiana Myeloma Registry

Summary: This is a prospective, non-interventional, observational study. The purpose of this study is to collect data and bio-specimens that will support future research

Who are the sources who wrote this article ?

Published Date: May 10, 2022
Published By: Genetic and Rare Diseases Informnation Center